Thirty-one patients with giant cell tumours of bone (BGCT) were treated at our hospital by a conservative approach between 1975 and 1988. 94% of the tumours were grade III (Campanacci) and the follow up was from 2 to 13 yeats. In the 20 patients who had a modified intralesional excision (curettage)
Macrophages in giant cell tumours of bone
β Scribed by G. W. Wood; J. R. Neff; K. A. Gollahon; W. K. Gourley
- Publisher
- John Wiley and Sons
- Year
- 1978
- Tongue
- English
- Weight
- 569 KB
- Volume
- 125
- Category
- Article
- ISSN
- 0022-3417
No coin nor oath required. For personal study only.
β¦ Synopsis
Five giant cell tumours of bone were studied to determine the degree of macrophage infiltration and whether the giant cells expressed the characteristics commonly associated with macrophages, i.e., IgGFc and C3 receptors, phagocytosis and non-specific esterase activity. Macrophages were assessed in trypsin-derived tumour cell suspensions by IgGEAC rosette formation and in frozen sections of tumour by EA adsorption. The percentage of macrophages in cell suspensions from four of the tumours ranged from 11 to 40 per cent. Strong EA adsorption occurred over 35 to 95 per cent. of the tumours' surface and significant non-specific esterase positivity was observed in the tumour sections. The giant cells were receptor negative and non-phagocytic, but a low percentage of them expressed esterase activity. The results strongly suggest that despite the fact that large numbers of macrophages were present in the tumours, the giant cells were derived from cells other than macrophages.
π SIMILAR VOLUMES
Macrophages are commonly found within osteolytic secondary carcinomas in bone, but the manner in which these cells contribute to malignant bone resorption is uncertain. Macrophages isolated from primary breast carcinomas were co-cultured for up to 21 days with UMR 106 rat osteoblast-like cells on bo